Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2023	$ 2	$ 191,569	$ (137,650)	$ 53,921
Balance (in shares) at Dec. 31, 2023	21,080,472
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		353		353
Exercise of stock options (in shares)	96,116
Issuance of common stock under stock incentive plans and exercise of stock options (in shares)	229,923
Stock-based compensation expense		1,714		1,714
Net Income (Loss)			(202)	(202)
Balance at Mar. 31, 2024	$ 2	193,636	(137,852)	55,786
Balance (in shares) at Mar. 31, 2024	21,406,511
Balance at Dec. 31, 2024	$ 2	199,460	(136,869)	62,593
Balance (in shares) at Dec. 31, 2024	22,059,697
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		29		$ 29
Exercise of stock options (in shares)	10,620			10,620
Issuance of common stock under stock incentive plans and exercise of stock options (in shares)	281,828
Stock-based compensation expense		1,577		$ 1,577
Net Income (Loss)			(1,166)	(1,166)
Balance at Mar. 31, 2025	$ 2	$ 201,066	$ (138,035)	$ 63,033
Balance (in shares) at Mar. 31, 2025	22,352,145